Is transformed small cell lung cancer (SCLC) different from

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed.

1. Exploring copy number alterations (CNAs) to gain new insight into SCLC heterogeneity.Molecular biology reports · 2026
   Review
2. Imaging of Small Cell Lung Cancer: An Updated Overview of Current and Emerging Applications.Radiology. Imaging cancer · 2026
   Review
3. Rare Combined Small-Cell Lung Carcinoma With Lymph Node Metastasis Exclusive to the Small-Cell Component: A Case Report.Cureus · 2025
   Article
4. Establishment and characterization of BMC-PDC-019: a novel patient-derived cell line of EGFR-mutant pulmonary adenocarcinoma transformed into small-cell lung cancer.Human cell · 2023
   Article
5. Exportin 1 inhibition prevents neuroendocrine transformation through SOX2 down-regulation in lung and prostate cancers.Science translational medicine · 2023
   Article
6. Patient-derived cell-based pharmacogenomic assessment to unveil underlying resistance mechanisms and novel therapeutics for advanced lung cancer.Journal of experimental & clinical cancer research : CR · 2023
   Article
7. An EGFR-mutant lung adenocarcinoma that transformed into small-cell lung cancer. A case report.Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia · 2022
   Article
8. Histologic transformation in lung cancer: when one door shuts, another opens.Therapeutic advances in medical oncology · 2022
   Review
9. RNA sequencing analysis of small cell lung cancer reveals candidate chemotherapy insensitivity long noncoding RNAs and microRNAs.Annals of translational medicine · 2020
   Article
10. Non-small cell lung cancer-small cell lung cancer transformation as mechanism of resistance to tyrosine kinase inhibitors in lung cancer.Cancer drug resistance (Alhambra, Calif.) · 2020
    Review
11. Targeting the EGFR signaling pathway in cancer therapy: What's new in 2023?Expert opinion on therapeutic targets
    Review

Corrections and comments

• Comment on
  A Brief Report of Transformation From NSCLC to SCLC: Molecular and Therapeutic Characteristics.2019

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.